Properties
                                        
                            Description
                            Trametinib prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells.
                         
                                                                            
                                                            
                            Molecular Formula
                            C28H29FIN5O5S
                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                            
                                                                                                                                                                                            
                            Identity
                            Confirmed by NMR/HPLC/MS.
                         
                                                                                                                                                            
                            Applications
                            Trametinib can be used to investigate the inhibition of MEK1/2 in cancer research and its therapeutic applications.